New drug combo tested for Tough-to-Treat liver cancer
Disease control
Recruiting now
This study is testing whether adding an experimental drug called WGI-0301 to the standard drug sorafenib can help control advanced liver cancer. It is for adults whose cancer has worsened after trying a previous type of immunotherapy. The main goals are to find the safest dose of…
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC